Is CBRX a good stock to own? Find out who bought Columbia Laboratories, who sold Columbia Laboratories (CBRX) stock, and who holds a large position in Columbia Laboratories.

• RA Capital Management owns 3.41M shares worth $8.53M
• Vanguard owns 1.82M shares worth $1.05M
• Ayer Capital Management owns 1.53M shares worth $2.99M
• Dr. Jeffrey R. Jay, M.D owns 1.53M shares worth $1.51M
• STATE STREET CORPORATION owns 1.15M shares worth $817082
• Kingdon Capital Management owns 950000 shares worth $560500
• JPMORGAN CHASE & CO owns 873285 shares worth $593833
• David M. Knott owns 660786 shares worth $419.93M
• GSA Capital Partners owns 653857 shares worth $385775
• Tudor Investment Corporation owns 626800 shares worth $445028
• S Squared Technology owns 621300 shares worth $1.55M
• MindShare Capital Management owns 530855 shares worth $525546
• Trellus Management Company owns 480000 shares worth $1.20M
• Lazard Asset Management owns 400000 shares worth $256000
• Austin W. Marxe and David M. Greenhouse owns 400000 shares worth $1000000
• TIAA-CREF Investment Management owns 383978 shares worth $272624
• Jay G. Goldman owns 307500 shares worth $698025
• Bridgeway Capital Management owns 259600 shares worth $184316
• Geode Capital Management owns 216630 shares worth $127811
• CalPERS owns 212600 shares worth $125434
• Renaissance Technologies owns 207249 shares worth $122276
• Hutchin Hill Capital owns 200000 shares worth $500000
• Technical Financial Services owns 197641 shares worth $494102
• Corsair Capital Management owns 191635 shares worth $113064
• UBS AG owns 190842 shares worth $188933
• GOLDMAN SACHS owns 186316 shares worth $184452
• Schroder Investment Management owns 173100 shares worth $117708
• Oxford Asset Management owns 167663 shares worth $107304
• Veritable owns 150000 shares worth $88500
• Two Sigma Investments owns 123196 shares worth $72685
• Bascom Hill Partners owns 115037 shares worth $287592
• ALLIANCEBERNSTEIN owns 107600 shares worth $76396
• Nomura Holdings owns 100978 shares worth $63616
• Charles Schwab Investment Management owns 98300 shares worth $68810

• Healthcare Value Capital sold on March 31, 2012
• HARRIS FINANCIAL sold on Sept. 30, 2011
• REINHART MAHONEY CAPITAL MANAGEMENT sold on Sept. 30, 2011
• Royal Bank of Canada sold on Sept. 30, 2011
• Wellington Management Company sold on Sept. 30, 2011
• Goldman Capital Management sold on June 30, 2011
• Credit Suisse AG sold on June 30, 2011
• D. E. Shaw & Co sold on June 30, 2011
• Harvest Management sold on June 30, 2011
• Millennium Management sold on March 31, 2011
• Artis Capital Management, L P sold on March 31, 2011
• S.A.C. Capital Advisors sold on March 31, 2011
• GLG Partners sold on March 31, 2011
• Perceptive Advisors sold on Dec. 31, 2010
• Diamondback Capital Management sold on Dec. 31, 2009

• AMAG Pharmaceuticals (AMAG)
• ArthroCare Corporation (ARTC)
• Vanda Pharmaceuticals (VNDA)
• Pain Therapeutics (PTIE)
• Alphatec Holdings (ATEC)
• NPS Pharmaceuticals (NPSP)
• Repligen Corporation (RGEN)
• Rigel Pharmaceuticals (RIGL)
• Sequenom (SQNM)
• Columbia Laboratories (CBRX)
• RTI Biologics (RTIX)
• Targacept (TRGT)
• Cardica (CRDC)
• Dex (DXCM)
• OncoGenex Pharmaceuticals (OGXI)
• Spectranetics Corporation (SPNC)
• Synergetics USA (SURG)
• ACADIA Pharmaceuticals (ACAD)
• Palatin Technologies (PTN)
• Discovery Laboratories (DSCOD)
• Oncothyreon (ONTY)